Jaakko Parkkinen Selected Research

Jaakko Parkkinen Research Topics

5	Reperfusion Injury 08/2011 - 03/2004
3	Acute Kidney Injury (Acute Renal Failure) 08/2011 - 03/2004
3	Infections 03/2004 - 11/2002
2	Pneumonia (Pneumonitis) 12/2019 - 09/2012
2	Ischemia 08/2011 - 03/2004
2	Neoplasms (Cancer) 10/2010 - 11/2009
2	Inflammation (Inflammations) 10/2004 - 03/2004
1	Hypoxia (Hypoxemia) 12/2019
1	Brain Death (Brain Dead) 01/2018
1	Flushing 01/2018
1	Acute Lung Injury 09/2012
1	Anemia 04/2012
1	Chronic Disease (Chronic Diseases) 04/2012
1	Iron Overload 02/2009
1	Hypothermia 04/2007
1	Edema (Dropsy) 02/2007
1	Ischemic Stroke 02/2007
1	Septic Shock (Toxic Shock Syndrome) 08/2004
1	Hematologic Neoplasms (Hematological Malignancy) 02/2002

6	IronIBA 04/2012 - 02/2002
4	CurcuminIBA 12/2019 - 10/2010
4	apotransferrinIBA 06/2004 - 06/2003
3	Transferrin (beta 2 Transferrin)IBA 11/2009 - 02/2002
2	AntioxidantsIBA 01/2018 - 04/2007
1	Hypoxia-Inducible Factor 1IBA 12/2019
1	InflammasomesIBA 12/2019
1	Hemolysin Proteins (Hemolysins)IBA 12/2019
1	NucleotidesIBA 12/2019
1	Leucine (L-Leucine)FDA Link 12/2019
1	DextrinsIBA 01/2018
1	dicarboxydine (DCD)IBA 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 04/2012
1	HepcidinsIBA 04/2012
1	Propofol (Diprivan)FDA LinkGeneric 08/2011
1	Bile Acids and Salts (Bile Acids)IBA 11/2009
1	Biological ProductsIBA 11/2009
1	Phosphotransferases (Kinase)IBA 04/2007
1	U 0126 (UO 126)IBA 04/2007
1	NADP (NADPH)IBA 04/2007
1	MitogensIBA 04/2007
1	Proteins (Proteins, Gene)FDA Link 04/2007
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2007
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2007
1	diphenyleneiodoniumIBA 04/2007
1	Neuroprotective AgentsIBA 02/2007
1	Hyaluronic Acid (Hyaluronan)IBA 02/2007
1	AlbuminsIBA 02/2007
1	FucoseIBA 10/2004
1	Glycoproteins (Glycoprotein)IBA 10/2004
1	HMGB1 Protein (HMG1)IBA 08/2004
1	Orosomucoid (Seromucoid)IBA 06/2004
1	holotransferrinIBA 03/2004
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2002